Formulation method improves bioavailability of poorly soluble molecules
Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.
Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.
As of March 30, coverage previously found on in-PharmaTechnologist will be hosted by our sister website, Outsourcing-Pharma.
Allergan’s intracameral sustained-release implant receives US FDA approval for two indications treating ophthalmic conditions.
Innovative Trials is set to work on increasing awareness within patient communities and improving engagement rates on behalf of Christie NHS Foundation Trust.
The two firms plan to use Saama’s Life Science Analytics Cloud platform to streamline clinical trial data management, using artificial intelligence technology.
The company’s Study Advance cloud-based platform combines access automation with real-world data on patient populations.
Project ALS has selected Medidata’s biomarker discovery solution for its research projects, aiming to improve understanding of the ALS disease process and develop new therapeutic strategies.
Paid for and content provided by Clinical Ink
As more and more people own smart phones, bring your own device (BYOD) patient data collection often makes sense. What are the risks and opportunities presented by such a strategy?